Rimonabant, gastrointestinal motility and obesity.

about

New approaches in the design and development of cannabinoid receptor ligands: multifunctional and bivalent compounds.Dissecting the cannabinergic control of behavior: The where matters.

P2860

Q38395251-59262809-A82D-48E2-8FB2-3F5C51FAE61A Q38564008-6413F955-92DF-4B66-989E-6525C2B562AD

P2860

Rimonabant, gastrointestinal motility and obesity.

Item

http://www.wikidata.org/entity/Q38085530

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Rimonabant, gastrointestinal motility and obesity.

@en

type

Item

label

Rimonabant, gastrointestinal motility and obesity.

@en

prefLabel

Rimonabant, gastrointestinal motility and obesity.

@en

P1476

Rimonabant, gastrointestinal motility and obesity.

@en

P2093

Jiande Dz Chen

http://www.w3.org/2001/XMLSchema#string

Yan Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Endocannabinoids and food intake: newborn suckling and appetite regulation in adulthood

Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation

The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats

Determination and characterization of a cannabinoid receptor in rat brain

Cannabinoid receptor signaling.

A systematic review on use of Chinese medicine and acupuncture for treatment of obesity.

Cannabinoids and the digestive tract.

Pharmacological characterization of cannabinoid receptor activity in the rat-isolated ileum myenteric plexus-longitudinal muscle preparation.

Cannabinoids for gastrointestinal diseases: potential therapeutic applications.

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.

P304

212-218

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/157015912803217297

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235756387

http://www.w3.org/2001/XMLSchema#string

P698

23449551

http://www.w3.org/2001/XMLSchema#string

P932

3468875

http://www.w3.org/2001/XMLSchema#string

Rimonabant, gastrointestinal motility and obesity.

about

P2860

P2860

Rimonabant, gastrointestinal motility and obesity.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932